Новый препарат «Искусственной слезы» Офтолик® в лечении больных с синдромом «Сухого глаза» различного генеза
Бржеский Владимир Всеволодович, Прозорная Людмила Петровна · CyberLeninK (CyberLeninka) · 2009
To study the clinical effect of a new artificial tears medication Ophtholique® (Promed Exports Pvt. Ltd.), 43 patients with dry eye syndrome were examined: 12 (22 eyes) due to perimenopause, 18 (32) due to meibomian blepharitis, and 13 (24) due to Sjogrens syndrome. It was established, that already after a single Ophtholique® instillation, there was a significant decrease of xerosis symptoms intensity, and a tear meniscus increase. Subsequent studies showed the high efficacy of systematic Ophtholique® instillations in the treatment of this category of patients. In general, the high efficacy of Ophtholique® in treatment of patients with different dry eye syndrome types, coupled with the absence of significant side-effects, allows recommending the wide use of this medication in clinical practice.
Cited by 0 works.